Par Pharmaceutical Companies, a developer and marketer of generic drugs, has announced that it will begin shipping generic versions of Imitrex injection 4mg and 6mg starter kits and 4mg and 6mg prefilled syringe cartridges. In addition, Par anticipates launching the 6mg vials in early 2009.
Subscribe to our email newsletter
Sumatriptan succinate injection is indicated for the acute treatment of migraine attacks with or without aura and the acute treatment of cluster headache episodes. Sumatriptan succinate injection is not for use in the management of hemiplegic or basilar migraine.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.